Roundtable Discussion; The Future of Mineral Sands. Watch the video here.
rugbyrob (last post), Posts: 604, Price: 4.55, No Opinion, RE: Dont get caught out, Wed 15:25.
100million definitely not priced in....with both and Business Update ....your talking over 20p
rugbyrob (second from last post), Posts: 604, Price: 5.50, No Opinion, RE: Dont get caught out, Tue 17:09.
Back after Christmas....I say another week if that, to finish the advanced negotiations...then its game on.
albibble, with ii you can put in a fill or kill order at your own set price
The ‘Suspended’ title has been removed from the Forbes Aquis stock page ??
https://www.aquis.eu/aquis-stock-exchange/member?securityidaqse=FOR
Directory of companies in the field of ASIC:
https://anysilicon.com/asic-manufacturers/
For 7-nm-or-under fabs, currently the only players in the industry with capacity for production are Intel, Samsung and TSMC.
The next gen Bitmain miners (s19xp) due for release July 2022 will use a TSMC 5nm.
Currently, the world’s fastest bitcoin miners on the market are crafted by firms like Bitmain, Canaan, and Microbt using chips between 12nm to 7nm.
Who did QBT partner with for their 5nm ASIC?
Yes, sash has gone in a green coffin here!
https://www.coindesk.com/business/2021/12/15/8-trends-that-will-shape-bitcoin-mining-in-2022/
The authors of this piece will need to add a significant update when our 'sustained orders of magnitude' RNS gets released
NEC Becomes First Global Reseller of D-Wave's Leap Quantum Cloud Service, December 06, 2021 11:00 ET. Source: D-Wave Systems Inc.
https://www.globenewswire.com/news-release/2021/12/06/2346774/0/en/NEC-Becomes-First-Global-Reseller-of-D-Wave-s-Leap-Quantum-Cloud-Service.html
Establishment of Quantum Strategic Industry Alliance for Revolution (Q-STAR), September 1, 2021
https://www.nec.com/en/press/202109/global_20210901_03.html
Q-STAR will invite the participation of diverse industries that support its objectives and initiatives, and will collaborate with industry, academia, and government in promoting initiatives that apply new technologies, and establishing related technology platforms. Q-STAR’s concerns include reassessments of basic principles and laws related to quantum technology, carrying out surveys and making recommendations on its applicability and on necessary industrial structures, systems, rules, etc. Q-STAR will also aim to establish a globally-recognized platform that will promote collaboration with other organizations around the world working in quantum technology.
https://bitcoinist.com/biggest-risk-for-bitcoin-quantum-computers-hurt-it/
We could do with The Telegraph providing an update to this article published on the 17 FEBRUARY 2021 • 4:41 PM
https://www.telegraph.co.uk/business/2021/02/17/affordable-british-made-covid-drug-could-slash-mortality-rates/amp/
My 2x buys yesterday at 0.0012 between 3pm & 4pm have not been printed yet, they were for 3795841 & 17583341 shares. I suspect there will be lots of delayed purchases coming through in the following days.
This is the site:
https://amcpharma-usa.com/
For those that wish to dig a bit deeper into ongoing clinical trials:
https://www.clinicaltrials.gov
ClinicalTrials.gov is a registry and results database of publicly and privately supported clinical studies of human participants conducted around the world.
Note that results information for registered and completed studies is submitted by the study sponsor or principal investigator, in a standard tabular format without discussions or conclusions. The information is considered summary information and does not include individual patient data.
https://www.fda.gov/drugs/development-approval-process-drugsFDA Accelerated ApprovalIn some cases, the approval of a new drug is expedited. Accelerated Approval can be applied to promising therapies that treat a serious or life-threatening condition and provide therapeutic benefit over available therapies. This approach allows for the approval of a drug that demonstrates an effect on a “surrogate endpoint” that is reasonably likely to predict clinical benefit, or on a clinical endpoint that occurs earlier but may not be as robust as the standard endpoint used for approval. This approval pathway is especially useful when the drug is meant to treat a disease whose course is long, and an extended period of time is needed to measure its effect. After the drug enters the market, the drug maker is required to conduct post-marketing clinical trials to verify and describe the drug’s benefit. If further trials fail to verify the predicted clinical benefit, FDA may withdraw approval.Since the Accelerated Approval pathway was established in 1992, many drugs that treat life-threatening diseases have successfully been brought to market this way and have made a significant impact on disease course. For example, many antiretroviral drugs used to treat HIV/AIDS entered the market via accelerated approval, and subsequently altered the treatment paradigm. A number of targeted cancer-fighting drugs also have come onto the market through this pathway.More information on Accelerated Approval is here:https://www.fda.gov/patients/fast-track-breakthrough-therapy-accelerated-approval-priority-review/accelerated-approval
https://themarketherald.com.au/mgc-pharma-asxmgc-makes-us-debut-with-33m-supply-deal-2021-08-27/amp/
https://www.proactiveinvestors.co.uk/companies/amp/news/958700?__twitter_impression=true
Toronto is GMT -5
Calgary is GMT -7
Tiburn, just rewatched the proactive interview again and it reaffirmed with me that the 7m shares of this that I hold in my ISA are a long term hold (at least till 2026). Having the potential of a dividend makes it even better in my opinion. Oilprice.com regularly has articles detailing the dividend rate that other US oil/gas producers issue, but I guess it’s all based on company performance anyway. We can only dream and wonder what the prospective dividend yield may be!